UNICEF "CANCER PLAN"
Here at Celltech, we have envisioned a brighter future for those who need it most. Through our partnership with the world changing charity, Unicef®, we aim to reduce the cancer affliction that faces some of the worlds most disadvantaged communities. We are piloting the scheme In a select few countries in Africa in early 2017. We plan to ship out thousands of vaccines to begin, eventually increasing exponentially. The first country that we are going to trial this in is Malawi. They will be the flagship country for this process. Assuming this is successful, we will then begin our trial scheme in Ethiopia and the Democratic Republic of Congo. Should the reception, coordination and assimilation of the vaccine program be successful in these three candidate countries, we can then begin the full scheme. This is a global effort that will include the poorest of 3rd world countries that will benefit from the Vaccine program the most. We are truly proud to be part of the Bioplus team and at the forefront of such a large undertaking. We are committed to reducing the number of cancer related deaths in the world by half by the year 2030. Other Charities have already shown an interest in the scheme and we will consider adding more to the portfolio in the years to come. This something that shall aid us in making it the largest global rollout of a vaccine to date, a goal which we anticipate to achieve in the years to come. We have also consulted with celebrities who are thrilled to offer their endorsement for our project such as, Akon, Robert De Niro and Bono and are thankful for their support and awareness they have brought to our revolutionary therapeutic.